Propel Bio Management, LLC: 13F holdings
CIK 19697642026Q2
| Positions | 29 |
|---|---|
| Reported value | $191.1m |
| Filed | 2026-08-13 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| PAGP PLAINS GP HOLDINGS LP-CL | 1,272,360 | $30.9m | 16.2% |
| ACHIEVE LIFE SCIENCES INC | 4,034,018 | $26.3m | 13.8% |
| CORT CORCEPT THERAPEUTICS INC | 136,499 | $11.9m | 6.2% |
| PHATHOM PHARMACEUTICALS I | 1,050,358 | $11.4m | 6.0% |
| DELCATH SYSTEMS INC | 871,460 | $11.0m | 5.7% |
| MILESTONE PHARMACEUTICALS | 7,429,590 | $10.0m | 5.2% |
| COMPASS PATHWAYS PLC | 573,086 | $8.1m | 4.2% |
| KYVERNA THERAPEUTICS INC | 883,198 | $7.9m | 4.1% |
| ARTIVA BIOTHERAPEUTICS IN | 696,436 | $6.8m | 3.5% |
| ABEONA THERAPEUTICS INC | 983,070 | $6.1m | 3.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1969764")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.